Meet Eurofins at PharmaLab Congress 2025 – Booth #26

We are thrilled to announce that Eurofins BioPharma Product Testing (BPT) Germany will be participating in the PharmaLab Congress 2025, taking place from November 24-26, 2025, in Düsseldorf, Germany. As one of the premier events in the pharmaceutical industry, PharmaLab Congress is the ideal platform to explore the latest innovations, regulatory updates, and industry trends.

Eurofins BPT Germany focusses in these key areas at PharmaLab conferences: GMP Compliance Trends Analytical Laboratories Laboratory Optimization, Automation and Digitalization Endotoxin and Pyrogen Testing Alternative and Rapid Microbiological Methods Cell and Gene Therapies/ ATMPs - Quality and Safety Bioassays/Potency Assays – Regulatory Requirements, Development and Routine Use Bioanalytical Control of Biological Drug Substances and Products
Event Information: Date: November 24-26, 2025 Booth Number: #26
Join us for presentations:  Title: Case studies for mRNA Therapeutics – Developing Reliable and Robust Potency Methods Speaker: Dr. Frances Reichert, Eurofins BPT Germany Time: November 24th, 4:30 pm Title: A Platform ddPCR Method for the Detection of Residual DNA in mRNA Samples Speaker: Dr. Christian Schiller, Eurofins BPT Germany Time: November 25th, 1:45 pm Title: Case Study: Validation and Bridging of a Flow Cytometry Potency Assay for a Therapeutic Monoclonal Antibody Speaker: Dr. Frances Reichert, Eurofins BPT Germany Time: November 25th, 4:30 pm Title: Shaping the Future of Pyrogen Testing: Regulatory Updates and the Role of MAT & Case Study: Qualification of a Reporter Gene-based Monocyte Activation Test Speaker: Dr. luca benedan, Eurofins BPT Italy & Dr. Nicole Rieth, Eurofins BPT Germany Time: November 26th, 11:30 am Title: Standardization Inside a Network of GMP Contract Laboratories Speaker: Dr. Christoph Hoppner, Eurofins BPT Europe Time: November 26th, 2:45 pm

• Expertise and Innovation
  At Eurofins, we are at the forefront of pharmaceutical quality control and testing. Our team of experts will be on hand to share insights into our cutting-edge services and solutions that ensure the highest standards of safety, efficacy, quality and compliance.
• Exclusive Presentations
  Attend our exclusive presentations where our specialists will discuss the latest advancements in pharmaceutical testing, including new methodologies, technologies, and regulatory requirements. Gain valuable knowledge that can help streamline your processes and enhance your product quality. More information will follow soon.
• Networking Opportunities­­­
  PharmaLab Congress is a prime opportunity to network with industry leaders, professionals, and peers. Meet with our team to discuss your specific needs, challenges, and how Eurofins can support your goals. Forge valuable connections and explore potential collaborations.
• Personalised Consultations
  Schedule a one-on-one consultation with our experts to receive personalised advice and solutions for your unique challenges. Whether you're looking to optimise your testing processes, comply with stringent regulations, or enhance your product quality, we are here to help.

About Eurofins BioPharma Product Testing:

Eurofins BioPharma Product Testing is the largest network of harmonized bio/pharmaceutical GMP product testing laboratories worldwide providing comprehensive laboratory services for the world's largest pharmaceutical, biopharmaceutical and medical device companies.

Our service offerings are fully comprehensive and include testing of drug substance, final product, intermediates, and starting materials for both small and large molecule drug products.

We give clients the flexibility to choose from three service models to meet specific project needs, including the award-winning PSS Insourcing Solutions^® and we also provide secure 24-hour data access via our online data portal, LabAccess.com^SM.

Our laboratories offer a broad range of methodologies under GMP authorization, ISO 17025 accreditation and ISO 9000 certification and all analysis are performed according to European and British Pharmacopeia (EP and BP), United States Pharmacopeia (USP) and Japanese Pharmacopeia (JP), as well as specific customer methods.

With a global capacity of more than 200,000 square meters and facilities located in Australia, Belgium, Canada, Czech Republic, Denmark, France, Germany, India, Ireland, Italy, Japan, Netherlands, New Zealand, Slovakia, Spain, Sweden, Switzerland, UK and the US, our network of GMP laboratories operates under the same strict quality procedures, LIMS and centralized billing system across more than 45 locations worldwide.

Follow Us: